Sampling and diversity of Escherichia coli from the enteric microbiota in patients with Escherichia coli bacteraemia.


Journal

BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768

Informations de publication

Date de publication:
13 Jun 2019
Historique:
received: 27 02 2019
accepted: 05 06 2019
entrez: 15 6 2019
pubmed: 15 6 2019
medline: 18 12 2019
Statut: epublish

Résumé

The increase in Escherichia coli bloodstream infections mandates better characterisation of the relationship between commensal and invasive isolates. This study adopted a simple approach to characterize E. coli in the gut reservoir from patients with either E. coli or other Gram-negative bacteraemia, or those without bacteraemia, establishing strain collections suitable for genomic investigation. Enteric samples from patients in the three groups were cultured on selective chromogenic agar. Genetic diversity of prevailing E. coli strains in gut microbiota was estimated by RAPD-PCR. Enteric samples from E. coli bacteraemia patients yielded a median of one E. coli RAPD pattern (range 1-4) compared with two (range 1-5) from groups without E. coli bacteraemia. Of relevance to large-scale clinical studies, observed diversity of E. coli among hospitalised patients was not altered by sample type (rectal swab or stool), nor by increasing the colonies tested from 10 to 20. Hospitalised patients demonstrated an apparently limited diversity of E. coli in the enteric microbiota and this was further reduced in those with E. coli bacteraemia. The reduced diversity of E. coli within the gut during E. coli bacteraemia raises the possibility that dominant strains may outcompete other lineages in patients with bloodstream infection.

Identifiants

pubmed: 31196206
doi: 10.1186/s13104-019-4369-y
pii: 10.1186/s13104-019-4369-y
pmc: PMC6563364
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

335

Subventions

Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Organisme : National Institute for Health Research
ID : HPRU-2012-10047

Références

Infect Immun. 2002 Mar;70(3):1225-9
pubmed: 11854204
J Clin Microbiol. 2008 Sep;46(9):3094-6
pubmed: 18650357
Nat Rev Microbiol. 2010 Jan;8(1):15-25
pubmed: 19946288
Clin Infect Dis. 2010 Aug 1;51(3):286-94
pubmed: 20572763
Epidemiol Infect. 1990 Oct;105(2):355-61
pubmed: 2209739
J Antimicrob Chemother. 2012 Jun;67(6):1514-24
pubmed: 22438437
J Clin Microbiol. 2012 Sep;50(9):3108-10
pubmed: 22785193
Sci Transl Med. 2013 May 8;5(184):184ra60
pubmed: 23658245
J Antimicrob Chemother. 2014 Jan;69(1):91-100
pubmed: 24003184
J Med Microbiol. 2014 Apr;63(Pt 4):582-9
pubmed: 24464694
J Microbiol Methods. 2014 Aug;103:101-3
pubmed: 24912108
Clin Microbiol Infect. 2015 Mar;21(3):251.e1-8
pubmed: 25698659
J Clin Microbiol. 2015 Jul;53(7):2122-31
pubmed: 25903575
Environ Microbiol Rep. 2015 Aug;7(4):642-8
pubmed: 26034010
Intensive Care Med. 2017 Mar;43(3):304-377
pubmed: 28101605
J Med Microbiol. 1980 Feb;13(1):45-56
pubmed: 7359576
Appl Environ Microbiol. 1998 Mar;64(3):1153-6
pubmed: 9501454
Avian Dis. 1998 Jul-Sep;42(3):431-51
pubmed: 9777144

Auteurs

Mia Mosavie (M)

Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.

Oliver Blandy (O)

Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.

Elita Jauneikaite (E)

Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.

Isabel Caldas (I)

Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.

Matthew J Ellington (MJ)

Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.
Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK.

Neil Woodford (N)

Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.
Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK.

Shiranee Sriskandan (S)

Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK. s.sriskandan@imperial.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH